Hanger Prosthetics & Orthotics Inc | |
5210 3rd St Ne, Ste B, Washington, District Of Columbia 20011 | |
(202) 635-0500 |
Name | Hanger Prosthetics & Orthotics Inc |
---|---|
Organization Name | Hanger Prosthetics & Orthotics Inc |
Location | 5210 3rd St Ne, Ste B, Washington, District Of Columbia 20011 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (202) 635-0500 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
NYU School of Medicine's Cosimo Commisso, PhD, a postdoctoral fellow in the Department of Biochemistry, is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research.
The addition of changes in inflammatory biomarkers to established clinical variables improves the prediction of mortality in patients with chronic obstructive pulmonary disease (COPD), according to a new study.
A new study uncovers which cell types can be infected by SARS-CoV-2 due to their viral entry factors. The study also suggests that increased gene expression of these viral entry factors in some individuals partially explains the differences of COVID-19 severity reported in relation to age, gender and smoking status.
› Verified 5 days ago
NPI Number | 1821162975 |
Organization Name | HANGER PROSTHETICS & ORTHOTICS INC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 5210 3rd St Ne Ste B, Washington, DC 20011 |
Phone Number | 202-635-0500 |
News Archive
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
NYU School of Medicine's Cosimo Commisso, PhD, a postdoctoral fellow in the Department of Biochemistry, is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research.
The addition of changes in inflammatory biomarkers to established clinical variables improves the prediction of mortality in patients with chronic obstructive pulmonary disease (COPD), according to a new study.
A new study uncovers which cell types can be infected by SARS-CoV-2 due to their viral entry factors. The study also suggests that increased gene expression of these viral entry factors in some individuals partially explains the differences of COVID-19 severity reported in relation to age, gender and smoking status.
› Verified 5 days ago
News Archive
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
NYU School of Medicine's Cosimo Commisso, PhD, a postdoctoral fellow in the Department of Biochemistry, is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research.
The addition of changes in inflammatory biomarkers to established clinical variables improves the prediction of mortality in patients with chronic obstructive pulmonary disease (COPD), according to a new study.
A new study uncovers which cell types can be infected by SARS-CoV-2 due to their viral entry factors. The study also suggests that increased gene expression of these viral entry factors in some individuals partially explains the differences of COVID-19 severity reported in relation to age, gender and smoking status.
› Verified 5 days ago
We Work Office Building Type: Durable Medical Equipment & Medical Supplies Supplier Location: 80 M St Se, Washington, District Of Columbia 20003 Phone: (844) 417-8633 | |
Aids Healthcare Foundation Type: Pharmacy Location: 2141 K St Nw, Washington, District Of Columbia 20037 Phone: (202) 293-8695 | |
All N 1 Medical Supplies & Treasure Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3811 Minnesota Ave Ne, Washington, District Of Columbia 20019 Phone: (202) 388-3300 | |
Bellevue Pharmacy Type: Community/Retail Pharmacy Location: 3939 S Capitol St Sw, Washington, District Of Columbia 20032 Phone: (202) 623-4221 | |
Capitol Medical Supply Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1618 7th St Nw, Washington, District Of Columbia 20001 Phone: (202) 667-1097 |